Levofloxacino Qualigen (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By preventing these enzymes from resealing DNA strands, the drug causes lethal DNA damage, resulting in a bactericidal effect against a broad range of Gram‑negative and Gram‑positive organisms.

The dosage of Levofloxacino Qualigen is determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Patients should follow the exact regimen provided by their health‑care professional.

Safety data for levofloxacin in pregnancy and lactation are limited, and the product is generally classified as contraindicated or used only when the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their health‑care provider.

To request Levofloxacino Qualigen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levofloxacin offers broad‑spectrum coverage and excellent tissue penetration, making it effective for many respiratory, urinary, and skin infections. Compared with beta‑lactams, it may be used when resistance to penicillins or cephalosporins is suspected, but it carries specific risks such as tendon injury and QT prolongation that are less common with some alternatives.

Levofloxacino Qualigen tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Levofloxacino Qualigen is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should avoid concurrent intake of antacids or supplements containing magnesium, aluminum, calcium, or iron, as these can reduce absorption.

Serious risks include tendon rupture (especially in older adults), QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, liver injury, and peripheral neuropathy. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, severe rash, or neurological symptoms.

Levofloxacino Qualigen should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, patients with a history of tendon disorders related to fluoroquinolone use, and those taking medications that significantly prolong the QT interval unless benefits outweigh risks. It is also contraindicated in patients with certain cardiac conditions and should be used with caution in renal impairment.